TipRanks
Go Ultimate55% OFF

Macquarie Group Limited (4M4) AI Stock Analysis

DE:4M4

Macquarie Group Limited

(Frankfurt:4M4)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Diversified earnings modelDiversification across recurring fees, lending income, client flows and investment activities reduces reliance on one revenue stream and supports resilience across economic cycles, regions and market environments.
Negative Factors
High leverageHigh leverage is common in financial services but increases sensitivity to funding costs, credit losses and market dislocation. It can also restrict strategic flexibility if capital requirements rise.

Macquarie Group Limited (4M4) vs. iShares MSCI Germany ETF (EWG)

-20%-10%0%10%20%30%40%DE:4M4+33.00%EWG+4.43%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 65.57B
Dividend Yield
2.67%
Average Volume (3M)
565
Price to Earnings (P/E)
19.8
Beta (1Y)
0.96
Revenue Growth
-1.53%
EPS Growth
23.25%
Country
Germany
Employees
19,124
Sector
Financial
Sector Strength
68
Industry
Investment - Banking & Investment Services

Macquarie Group Limited Business Overview & Revenue Model

Company Description

Macquarie Group Limited provides diversified financial services in Australia, New Zealand the Americas, Europe, the Middle East, Africa, and Asia. It operates through four segments: Macquarie Asset Management (MAM); Banking and Financial Services (BF...

Macquarie Group Limited Earnings Call Summary

Earnings Call Date:May 06, 2026(Q4-2026)|% Change Since:7.70%|Next Earnings Date:Jul 27, 2021
Earnings Call SentimentPositive

The call reported a strong set of results with materially higher profit, revenue growth across multiple lines, robust deposit and loan expansion, notable increases in performance fees and private credit momentum, and an improved capital position. These positives are tempered by elevated credit impairment provisions (primarily in H2), impairments and losses in the green investments portfolio, increased regulatory capital usage in CGM, and management's cautious tone about uncertain market conditions that could moderate client-driven revenues. On balance the operational and financial progress and balance sheet strength outweigh the challenges reported.

Positive Updates

Record Net Profit and Strong ROE
Group net profit after tax of $4.847 billion, up 30% year-on-year. Return on equity (ROE) of 14%, a 25% improvement from just over 11% in the prior year.

Negative Updates

Increased Credit Impairments
Credit impairment charge for the year of $478 million, with $461 million taken in the second half reflecting increased modeled provisions and loan book growth amid macro uncertainty.

Company Guidance

Guidance was cautious but broadly constructive — management expects short‑term income for Macquarie to be largely in line with FY26 while remaining sensitive to market conditions: MAM base fees broadly in line (MAM contribution $2.6bn; AUM $722bn; private markets AUM ~$218bn, +$27bn year‑on‑year, with ~$21bn dry powder); BFS to grow through loans, deposits and platform flows (BFS profit $1.61bn; home loans ~ $181bn, +28%; deposits ~ $215–222bn, +25%; funds on platform +1%; 2.3m clients); CGM net operating income expected broadly in line excluding the FY26 OnStream realization (CGM contribution $4.221bn; commodities income ~$3.6bn; asset finance book $7.6bn, +25%); Macquarie Capital broadly in line subject to transaction/investment activity (MacCap profit $1.491bn; private credit ~ $27bn, earning ~4–4.5%). At group level they expect compensation and effective tax rates broadly in line (FY26 ETR 27.6%), continue to hold a prudent stance on funding/capital/liquidity (capital surplus $9.3bn, CET1 12.8%, term funding issued ~$30bn with WAL ~4.1 years, LCR/NSFR comfortably above minima), and to maintain disciplined costs and investment (group net operating income $19.5bn; operating expenses $12.7bn; tech spend +5% to ~20% of expenses); capital management includes a FY26 dividend of $7.00 (H2 $4.20, H2 payout ratio ~50%, FY payout ratio ~55%), DRP discount 1.5% and conclusion of the on‑market buyback.

Macquarie Group Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (68)

Financial Indicators

DE:4M4 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *68Neutral$18.00B11.429.92%3.81%9.73%1.22%
AU:RZIAU:RZI66NeutralAUD 44.26M12.508.01%―21.42%―
AU:PPSAU:PPS64NeutralAUD 280.30M41.675.79%4.35%7.20%-51.06%
AU:NWLAU:NWL56NeutralAUD 4.44B71.8838.95%2.33%21.01%-48.10%
AU:OFXAU:OFX54NeutralAUD 97.76M-233.33-0.22%―-7.93%-101.72%
AU:ABEAU:ABE53NeutralAUD 5.76M-3.2777.55%―31.21%67.68%

* Financial Sector Average

Performance Comparison

-50%-25%0%25%DE:4M4AU:RZIAU:PPSAU:ABEAU:OFXAU:NWLDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
DE:4M4 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:4M4Macquarie Group Limited156.6237.8431.85%
AU:RZIRaiz Invest Ltd.0.42-0.50-54.10%
AU:PPSPraemium Ltd0.57-0.30-34.44%
AU:ABEAustralian Bond Exchange Holdings Ltd.0.040.0116.67%
AU:OFXOFX Group Ltd.0.42-0.18-30.00%
AU:NWLNetwealth Group Ltd.18.05-12.18-40.30%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.